Related references
Note: Only part of the references are listed.Effect of processing methods on colouration of human serum albumin preparations
Karl B. McCann et al.
BIOLOGICALS (2009)
Glucose Control in the ICU - How Tight Is Too Tight?
Silvio E. Inzucchi et al.
NEW ENGLAND JOURNAL OF MEDICINE (2009)
Design, conduct, analysis and reporting of a multi-national placebo-controlled trial of activated protein C for persistent septic shock
Simon Finfer et al.
INTENSIVE CARE MEDICINE (2008)
The risk associated with hyperoncotic colloids in patients with shock
Frederique Schortgen et al.
INTENSIVE CARE MEDICINE (2008)
Corticosteroids in septic shock
Simon Finfer
NEW ENGLAND JOURNAL OF MEDICINE (2008)
Intensive insulin therapy and pentastarch resuscitation in severe sepsis
Frank M. Brunkhorst et al.
NEW ENGLAND JOURNAL OF MEDICINE (2008)
Surviving Sepsis Campaign: International guidelines for management of severe sepsis and septic shock: 2008
R. Phillip Dellinger et al.
INTENSIVE CARE MEDICINE (2008)
Incidence, treatment, and outcome of severe sepsis in ICU-treated adults in Finland: the Finnsepsis study
Sari Karlsson et al.
INTENSIVE CARE MEDICINE (2007)
Effect of baseline serum albumin concentration on outcome of resuscitation with albumin or saline in patients in intensive care units: analysis of data from the saline versus albumin fluid evaluation (SATE) study
Simon Finfer et al.
BRITISH MEDICAL JOURNAL (2006)
Volume expansion with albumin compared to gelofusine in children with severe malaria: Results of a controlled trial
Samuel Akech et al.
PLOS CLINICAL TRIALS (2006)
Sepsis in European intensive care units: Results of the SOAP study
JL Vincent et al.
CRITICAL CARE MEDICINE (2006)
Comparison of three fluid solutions for resuscitation in dengue shock syndrome
BA Wills et al.
NEW ENGLAND JOURNAL OF MEDICINE (2005)
Randomized trial of volume expansion with albumin or saline in children with severe malaria: Preliminary evidence of albumin benefit
K Maitland et al.
CLINICAL INFECTIOUS DISEASES (2005)
Adult-population incidence of severe sepsis in Australian and New Zealand intensive care units
S Finfer et al.
INTENSIVE CARE MEDICINE (2004)
Albumin influences total plasma antioxidant capacity favorably in patients with acute lung injury
GJ Quinlan et al.
CRITICAL CARE MEDICINE (2004)
Preferred plasma volume expanders for critically ill patients: results of an international survey
F Schortgen et al.
INTENSIVE CARE MEDICINE (2004)
Albumin and furosemide therapy in hypoproteinemic patients with acute lung injury
GS Martin et al.
CRITICAL CARE MEDICINE (2002)
Albumin selectively inhibits TNFα-induced expression of vascular cell adhesion molecule-1 in human aortic endothelial cells
WJ Zhang et al.
CARDIOVASCULAR RESEARCH (2002)
Effect of treatment with low doses of hydrocortisone and fludrocortisone on mortality in patients with septic shock
D Annane et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2002)
Influences on physicians' choices of intravenous colloids
MS Miletin et al.
INTENSIVE CARE MEDICINE (2002)
Early goal-directed therapy in the treatment of severe sepsis and septic shock.
E Rivers et al.
NEW ENGLAND JOURNAL OF MEDICINE (2001)
Intensive insulin therapy in critically ill patients.
G Van den Berghe et al.
NEW ENGLAND JOURNAL OF MEDICINE (2001)
Effects of hydroxyethylstarch and gelatin on renal function in severe sepsis: a multicentre randomised study
F Schortgen et al.
LANCET (2001)
Efficacy and safety of recombinant human activated protein C for severe sepsis.
GR Bernard et al.
NEW ENGLAND JOURNAL OF MEDICINE (2001)
Share Paper
